Literature DB >> 20151203

Diet and visually significant cataracts in galactosaemia: is regular follow up necessary?

John Widger1, Jennifer O'Toole, Olivia Geoghegan, Micheal O'Keefe, Rosemarie Manning.   

Abstract

INTRODUCTION: Classic galactosaemia is caused by a recessively inherited deficiency of the enzyme galactose 1 phosphate uridyl transferase (GALT). Patients with classical galactosaemia are at increased risk of developing cataracts. We sought to retrospectively review the incidence and severity of cataracts in the cohort of galactosaemia patients attending our national treatment centre and to assess a possible effect of dietary compliance on cataract formation and the benefits of regular ophthalmic follow-up.
METHODS: We retrospectively reviewed the clinical notes of all patients currently attending our centre with classic galactosaemia and identified all those in whom cataracts had been diagnosed by an ophthalmologist. Compliance to diet was also reviewed and compared with a matched control group.
RESULTS: Of 100 active patient charts, 14 had cataracts diagnosed at some stage. Six of these persisted whereas eight regressed. Three occurred soon after birth. Age at cataract formation varied from soon after birth to 19 years of age. There was no significant difference in the cataract group between those who were compliant and those who were noncompliant with diet (p = 0.09). There was no difference in compliance between the cataract group and the control group (p = 0.16). None of the cataracts found were affecting vision.
CONCLUSION: Cataracts affecting vision were not found in our cohort. A direct relationship between dietary compliance and cataract formation was not demonstrated. On the basis of our data, regular life-long ophthalmic exam of patients with classic galactosemia seems to be unnecessary. TAKE-HOME MESSAGE: Cataracts which develop in patients with classical Galactosaemia do not usually affect vision and may be unrelated to compliance to diet.

Entities:  

Mesh:

Year:  2010        PMID: 20151203     DOI: 10.1007/s10545-009-9042-5

Source DB:  PubMed          Journal:  J Inherit Metab Dis        ISSN: 0141-8955            Impact factor:   4.982


  9 in total

1.  Recommendations for the management of galactosaemia. UK Galactosaemia Steering Group.

Authors:  J H Walter; J E Collins; J V Leonard
Journal:  Arch Dis Child       Date:  1999-01       Impact factor: 3.791

2.  Genetic basis of transferase-deficient galactosaemia in Ireland and the population history of the Irish Travellers.

Authors:  M Murphy; B McHugh; O Tighe; P Mayne; C O'Neill; E Naughten; D T Croke
Journal:  Eur J Hum Genet       Date:  1999-07       Impact factor: 4.246

3.  Birth prevalence of visually significant infantile cataract in a defined U.S. population.

Authors:  Jonathan M Holmes; David A Leske; James P Burke; David O Hodge
Journal:  Ophthalmic Epidemiol       Date:  2003-04       Impact factor: 1.648

4.  Incidence and cumulative risk of childhood cataract in a cohort of 2.6 million Danish children.

Authors:  Birgitte Haargaard; Jan Wohlfahrt; Hans Callø Fledelius; Thomas Rosenberg; Mads Melbye
Journal:  Invest Ophthalmol Vis Sci       Date:  2004-05       Impact factor: 4.799

5.  Ophthalmic findings in classical galactosaemia--prospective study.

Authors:  B Beigi; M O'Keefe; R Bowell; E Naughten; N Badawi; B Lanigan
Journal:  Br J Ophthalmol       Date:  1993-03       Impact factor: 4.638

6.  Long-term outcome in 134 patients with galactosaemia.

Authors:  S Schweitzer; Y Shin; C Jakobs; J Brodehl
Journal:  Eur J Pediatr       Date:  1993-01       Impact factor: 3.183

7.  Aetiology of congenital and paediatric cataract in an Australian population.

Authors:  M G Wirth; I M Russell-Eggitt; J E Craig; J E Elder; D A Mackey
Journal:  Br J Ophthalmol       Date:  2002-07       Impact factor: 4.638

8.  Galactosemia: how does long-term treatment change the outcome?

Authors:  R Gitzelmann; B Steinmann
Journal:  Enzyme       Date:  1984

9.  Endogenous synthesis of galactose in normal men and patients with hereditary galactosaemia.

Authors:  G T Berry; I Nissim; Z Lin; A T Mazur; J B Gibson; S Segal
Journal:  Lancet       Date:  1995-10-21       Impact factor: 79.321

  9 in total
  6 in total

1.  Classical Galactosaemia in Ireland: incidence, complications and outcomes of treatment.

Authors:  K P Coss; P P Doran; C Owoeye; M B Codd; N Hamid; P D Mayne; E Crushell; I Knerr; A A Monavari; E P Treacy
Journal:  J Inherit Metab Dis       Date:  2012-07-03       Impact factor: 4.982

2.  A rare galactosemia complication: vitreous hemorrhage.

Authors:  Sahin Takci; Sibel Kadayifcilar; Turgay Coskun; Sule Yigit; Burcu Hismi
Journal:  JIMD Rep       Date:  2011-12-11

Review 3.  Appropriateness of newborn screening for classic galactosaemia: a systematic review.

Authors:  L Varela-Lema; L Paz-Valinas; G Atienza-Merino; R Zubizarreta-Alberdi; R Vizoso Villares; M López-García
Journal:  J Inherit Metab Dis       Date:  2016-04-26       Impact factor: 4.982

4.  Clinical, molecular, and genetic evaluation of galactosemia in Turkish children.

Authors:  Sezen Ugan Atik; Semra Gürsoy; Tuba Koçkar; Hasan Önal; Servet Erdal Adal
Journal:  Turk Pediatri Ars       Date:  2016-12-01

5.  A case of galactosemia misdiagnosed as cow's milk intolerance.

Authors:  Roberto Della Casa; Carla Ungaro; Emma Acampora; Claudio Pignata; Pietro Vajro; Mariacarolina Salerno; Francesca Santamaria; Giancarlo Parenti
Journal:  Ital J Pediatr       Date:  2012-09-19       Impact factor: 2.638

6.  Pilot study of classic galactosemia: Neurodevelopmental impact and other complications urge neonatal screening in Egypt.

Authors:  Magd A Kotb; Lobna Mansour; Christine William Shaker Basanti; Wael El Garf; Ghada I Z Ali; Sally T Mostafa El Sorogy; Inas E M Kamel; Naglaa M Kamal
Journal:  J Adv Res       Date:  2018-02-23       Impact factor: 10.479

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.